ALDMS — DIAGNOSTIC MEDICAL SYSTEMS SA Share Price
Last trade - 00:00- €22.31m
- €37.66m
- €46.07m
- 44
- 62
- 85
- 73
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 10.7 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.74 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 6.19 | ||
| Price to Sales | 0.48 | ||
| EV to EBITDA | 16.91 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.14% | ||
| Return on Equity | -22.84% | ||
| Operating Margin | -0.75% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 32.19 | 36.96 | 35.27 | 42.15 | 46.07 | 56 | 60.8 | 8.24% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
DIAGNOSTIC MEDICAL SYSTEMS SA, (formerly known as DMS), is a France-based company, which together with its subsidiaries, designs, produces and markets medical imagery devices dedicated to conventional and digital radiology as well as bone densitometry. The Company manufactures a range of products for bone densitometry examination, including the ultrasound imaging system UBIS 5000, Challenger Envision, Stratos dR and Stratos. In the radiology sector, its products include Baccara dRF 43, EOL, Platinum and Da Vinci solutions, among others. In addition, it offers such products as scanners, transcranial Doppler, and Giotto Image mammography system. The Company operates several direct subsidiaries, AXS Medical, Apelem SAS, which manufactures radiology equipment, Medilink SARL, which produces Doppler and bone densitometry devices, Apelem SA, based in Spain, Alpha MOS based in France and one indirect subsidiary, SA Apelem and one indirect affiliated company, Spectrap.
Directors
- Jean-Paul Ansel CHM (72)
- Samuel Sancerni DCE
- Jean-Philippe Dross OTH
- Laure Landucci OTH
- Michael Sifre OTH
- David Terreehorst OTH
- Richard Voisinne OTH
- Simonyi See-Nuan DRC
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 15th, 1993
- Public Since
- January 1st, 1998
- No. of Employees
- 144
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 20,852,300
- Address
- 9 Avenue du Canal Philippe, GALLARGUES-LE-MONTUEUX, 30660
- Web
- https://www.dms-imaging.com/
- Phone
- +33 467504900
- Auditors
- SELARL Donnadieu Dehors Alvarez
Upcoming Events for ALDMS
Similar to ALDMS
AbL Diagnostics SA
Euronext - Paris
Affluent Medical SAS
Euronext - Paris
Amplitude Surgical SA
Euronext - Paris
Aton SA
Euronext - Paris
Biomerieux SA
Euronext - Paris
FAQ
As of Today at 20:14 UTC, shares in DIAGNOSTIC MEDICAL SYSTEMS SA are trading at €1.07. This share price information is delayed by 15 minutes.
Shares in DIAGNOSTIC MEDICAL SYSTEMS SA last closed at €1.07 and the price had moved by +2.87% over the past 365 days. In terms of relative price strength the DIAGNOSTIC MEDICAL SYSTEMS SA share price has outperformed the FTSE Global All Cap Index by +0.29% over the past year.
The overall consensus recommendation for DIAGNOSTIC MEDICAL SYSTEMS SA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreDIAGNOSTIC MEDICAL SYSTEMS SA does not currently pay a dividend.
DIAGNOSTIC MEDICAL SYSTEMS SA does not currently pay a dividend.
DIAGNOSTIC MEDICAL SYSTEMS SA does not currently pay a dividend.
To buy shares in DIAGNOSTIC MEDICAL SYSTEMS SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €1.07, shares in DIAGNOSTIC MEDICAL SYSTEMS SA had a market capitalisation of €22.31m.
Here are the trading details for DIAGNOSTIC MEDICAL SYSTEMS SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALDMS
Based on an overall assessment of its quality, value and momentum DIAGNOSTIC MEDICAL SYSTEMS SA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in DIAGNOSTIC MEDICAL SYSTEMS SA is €1.80. That is 68.26% above the last closing price of €1.07.
Analysts covering DIAGNOSTIC MEDICAL SYSTEMS SA currently have a consensus Earnings Per Share (EPS) forecast of €0.10 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DIAGNOSTIC MEDICAL SYSTEMS SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +20.59%.
As of the last closing price of €1.07, shares in DIAGNOSTIC MEDICAL SYSTEMS SA were trading +19.79% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The DIAGNOSTIC MEDICAL SYSTEMS SA PE ratio based on its reported earnings over the past 12 months is 10.7. The shares last closed at €1.07.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
DIAGNOSTIC MEDICAL SYSTEMS SA's management team is headed by:
- Jean-Paul Ansel - CHM
- Samuel Sancerni - DCE
- Jean-Philippe Dross - OTH
- Laure Landucci - OTH
- Michael Sifre - OTH
- David Terreehorst - OTH
- Richard Voisinne - OTH
- Simonyi See-Nuan - DRC